Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Houston American Energy Corp HUSA

Houston American Energy Corp. is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its principal properties, and operations, are in the United States Permian Basin and the South American country of Colombia. Additionally, it has properties in the Louisiana United States Gulf Coast region. Its Texas properties include Reeves County and Yoakum County. It holds an 18.1% average working interest in 320 gross acres in Reeves County, Texas, consisting of over 160 gross acres Johnson Lease and 160 gross acres O’Brien Lease, in which the Company holds an average 11.2% working interest. Its property in Louisiana consists of a 23.4% mineral interest in 2,485 gross acres in East Baton Rouge Parish. It has interests in a single block, through Hupecol Meta, LLC, operated by Hupecol Operating and affiliates, in Colombia, covering approximately 639,405 gross acres.


NYSEAM:HUSA - Post by User

Post by GwenTracyon Jun 03, 2022 5:21am
121 Views
Post# 34728769

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance



FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


 
<< Previous
Bullboard Posts
Next >>